TY - JOUR AU - Shih, Andrew W.; Sheppard, Jo-Ann I.; Warkentin, Theodore E. TI - Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review SN - 0340-6245 SN - 2567-689X PY - 2017 JO - Thromb Haemost JF - Thrombosis and Haemostasis LA - EN VL - 117 IS - 10 SP - 1868 EP - 1874 DA - 2017/11/08 KW - Deep vein thrombosis KW - heparins KW - pulmonary embolism KW - thrombosis AB - One of the standard distinctions between type 1 (non-immune) and type 2 (immune-mediated) heparin-induced thrombocytopenia (HIT) is the transience of thrombocytopenia: type 1 HIT is viewed as early-onset and transient thrombocytopenia, with platelet count recovery despite continuing heparin administration. In contrast, type 2 HIT is viewed as later-onset (i. e., 5 days or later) thrombocytopenia in which it is generally believed that platelet count recovery will not occur unless heparin is discontinued. However, older reports of type 2 HIT sometimes did include the unexpected observation that platelet counts could recover despite continued heparin administration, although without information provided regarding changes in HIT antibody levels in association with platelet count recovery. In recent years, some reports of type 2 HIT have confirmed the observation that platelet count recovery can occur despite continuing heparin administration, with serological evidence of waning levels of HIT antibodies (“seroreversion”). We now report two additional patient cases of type 2 HIT with platelet count recovery despite ongoing therapeutic-dose (1 case) or prophylactic-dose (1 case) heparin administration, in which we demonstrate concomitant waning of HIT antibody levels. We further review the literature describing this phenomenon of HIT antibody seroreversion and platelet count recovery despite continuing heparin administration. Our observations add to the concept that HIT represents a remarkably transient immune response, including sometimes even when heparin is continued. PB - Schattauer GmbH DO - 10.1160/TH17-03-0212 UR - http://www.thieme-connect.com/products/ejournals/abstract/10.1160/TH17-03-0212 ER -